Rutgers Cancer Institute of New Jersey
195 Little Albany Street
New Brunswick, NJ 08903-2681
732-235-CINJ (2465)
New Brunswick, N.J. - Mentored by scientists from Rutgers Cancer Institute of New Jersey at Princeton University and Rutgers University, early-career investigators received a combined $1,600,000 in funding to support basic science research that could impact breast, colorectal, lung and other cancers. The Pre- and Post-Doctoral Fellowship Grants were awarded by the New Jersey Commission on Cancer Research (NJCCR).
“Investing in cancer research is vital, as seminal discoveries in the laboratory translate to cancer treatments of the future. As New Jersey’s only National Cancer Institute-designated Comprehensive Cancer Center, Rutgers Cancer Institute is committed to mentoring the next generation of investigators so that we may learn more about the underlying mechanisms of cancer. We thank the New Jersey Commission on Cancer Research for its support and sharing in our mission,” notes Rutgers Cancer Institute Deputy Director, Chief Scientific Officer and Associate Director for Basic Science Eileen White, PhD, who is also a distinguished professor of molecular biology and biochemistry in the School of Arts and Sciences at Rutgers University.
“Collaboration between academic institutions, industry and other organizations is critical when it comes to elucidating the inner workings of cancer. This support from the New Jersey Commission on Cancer Research enables basic research programs at Rutgers Cancer Institute and Princeton and Rutgers Universities to work together to fuel innovative breakthroughs that will impact tomorrow’s patients. We are grateful to NJCCR for its support,” adds Rutgers Cancer Institute Associate Director for Consortium Research Yibin Kang, PhD, who is also the Warner-Lambert/Parke-Davis Professor of Molecular Biology at Princeton University. Princeton University and Rutgers Cancer Institute have been partnering as a cancer research consortium for nearly a decade.
The following investigators received a Post-Doctoral Fellowship Award in the amount of $100,000 each:
The following investigators received a Pre-Doctoral Fellowship Award in the amount of $50,000 each:
The award period runs through 2019.
About Rutgers Cancer Institute of New Jersey
Rutgers Cancer Institute, along with its partner RWJBarnabas Health, offers the most advanced cancer treatment options including clinical trials and novel therapeutics such as precision medicine and immunotherapy – many of which are not available at other facilities across the state. Patients have access to these cutting-edge therapies throughout the state at Rutgers Cancer Institute of New Jersey in New Brunswick, Rutgers Cancer Institute of New Jersey at University Hospital in Newark, as well as at RWJBarnabas Health.
Along with world-class treatment, which is often fueled by on-site research conducted in Rutgers Cancer Institute laboratories, patients and their families also can seek cancer preventative services and education resources throughout the Rutgers Cancer Institute and RWJBarnabas Health footprint statewide. To make a tax-deductible gift to support the Cancer Institute of New Jersey, call 848-932-8013 or visit www.cinj.org/giving.
For journalists – contact:
Michele Fisher, Media Relations Specialist
732-235-9872
For patient appointments/inquiries – contact:
732-235-8515